Rivastigmine For Methamphetamine Dependent Individuals

Clinical trial NCT00158210 · COMPLETED

Trial details

NCT number: NCT00158210
Sponsor: National Institute on Drug Abuse (NIDA)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Substance-Related Disorders

Start date: 2006-05-01
Primary completion: 2007-03-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.